NCT03050801View on ClinicalTrials.gov

Functional Connectivity as a Biomarker of rTMS

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

March 24, 2017

Primary Completion Date

March 10, 2020

Study Completion Date

August 7, 2020

Conditions
Traumatic Brain Injury
Interventions
DEVICE

rTMS

Altering the connectivity of trans-synaptic pathways

Trial Locations (1)

20892

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Institute of Neurological Disorders and Stroke (NINDS)

NIH

NCT03050801 - Functional Connectivity as a Biomarker of rTMS | Biotech Hunter | Biotech Hunter